Pinnacle Wealth Planning Services, Inc. Ionis Pharmaceuticals Inc Transaction History
Pinnacle Wealth Planning Services, Inc.
- $838 Million
- Q3 2025
A detailed history of Pinnacle Wealth Planning Services, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Pinnacle Wealth Planning Services, Inc. holds 5,113 shares of IONS stock, worth $365,835. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,113
Previous 5,284
3.24%
Holding current value
$365,835
Previous $208,000
60.58%
% of portfolio
0.04%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
506Shares Held
155MCall Options Held
2.69MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.18 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD13.2MShares$941 Million0.53% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$910 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$738 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.59MShares$471 Million0.08% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.2B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...